000597 东北制药
已收盘 02-04 15:00:00
资讯
新帖
简况
东北制药（000597）披露诉讼进展公告，2月2日股价下跌2.83%
证券之星 · 02-02 17:56
东北制药（000597）披露诉讼进展公告，2月2日股价下跌2.83%
东北制药：截至2025年12月31日持有人数约4.74万
证券之星 · 01-08
东北制药：截至2025年12月31日持有人数约4.74万
东北制药（000597）披露非独立董事辞职暨选举职工代表董事公告，1月6日股价上涨0.38%
证券之星 · 01-06
东北制药（000597）披露非独立董事辞职暨选举职工代表董事公告，1月6日股价上涨0.38%
东北制药：截至2025年12月19日持有人数约4.80万
证券之星 · 2025-12-24
东北制药：截至2025年12月19日持有人数约4.80万
东北制药最新公告：开展股东回馈活动
证券之星 · 2025-12-23
东北制药最新公告：开展股东回馈活动
东北制药：截至2025年12月10日持有人数约4.80万
证券之星 · 2025-12-19
东北制药：截至2025年12月10日持有人数约4.80万
东北制药（000597）披露取消监事会及修订公司章程等议案获股东会通过，12月15日股价下跌1.31%
证券之星 · 2025-12-15
东北制药（000597）披露取消监事会及修订公司章程等议案获股东会通过，12月15日股价下跌1.31%
东北制药：截至2025年11月最后一个交易日持有人数约4.82万
证券之星 · 2025-12-03
东北制药：截至2025年11月最后一个交易日持有人数约4.82万
东北制药：截至2025年11月20日持有人数约4.79万
证券之星 · 2025-11-27
东北制药：截至2025年11月20日持有人数约4.79万
东北制药(000597)9月30日股东户数4.97万户，较上期减少0.41%
证券之星 · 2025-10-28
东北制药(000597)9月30日股东户数4.97万户，较上期减少0.41%
图解东北制药三季报：第三季度单季净利润同比下降14.92%
证券之星 · 2025-10-28
图解东北制药三季报：第三季度单季净利润同比下降14.92%
东北制药(000597)9月30日股东户数4.97万户，较上期减少0.4%
证券之星 · 2025-10-14
东北制药(000597)9月30日股东户数4.97万户，较上期减少0.4%
股市必读：东北制药(000597)股东户数4.99万户，较上期减少2.35%
证券之星 · 2025-10-09
股市必读：东北制药(000597)股东户数4.99万户，较上期减少2.35%
东北制药：千余名员工坚守岗位 书写保产保供“节日答卷”
滚动播报 · 2025-10-05
东北制药：千余名员工坚守岗位 书写保产保供“节日答卷”
东北制药(000597)9月19日股东户数4.99万户，较上期减少2.35%
证券之星 · 2025-09-30
东北制药(000597)9月19日股东户数4.99万户，较上期减少2.35%
东北制药最新公告：聘任李新为公司财务总监
证券之星 · 2025-09-07
东北制药最新公告：聘任李新为公司财务总监
东北制药：维生素C产品可用作抗氧化剂清除活性氧自由基
证券之星 · 2025-09-04
东北制药：维生素C产品可用作抗氧化剂清除活性氧自由基
东北制药(000597.SZ)：财务总监周雅娜辞职
格隆汇 · 2025-09-01
东北制药(000597.SZ)：财务总监周雅娜辞职
东北制药（000597）2025年中报简析：净利润同比下降17.62%
证券之星 · 2025-08-28
东北制药（000597）2025年中报简析：净利润同比下降17.62%
图解东北制药中报：第二季度单季净利润同比下降6.37%
证券之星 · 2025-08-27
图解东北制药中报：第二季度单季净利润同比下降6.37%
加载更多
公司概况
公司名称：
东北制药集团股份有限公司
所属行业：
医药制造业
上市日期：
1996-05-23
主营业务：
东北制药集团股份有限公司的主营业务是化学制药、医药商业、医药工程、生物医药等板块。公司的主要产品是维生素类、抗感染类、生殖系统和性激素类、神经系统类、抗艾滋病类、消化道类、麻精及含麻系列类、其他普药类、体外（生物）诊断试剂类。
发行价格：
6.68
{"stockData":{"symbol":"000597","market":"SZ","secType":"STK","nameCN":"东北制药","latestPrice":5.26,"timestamp":1770188619000,"preClose":5.2,"halted":0,"volume":12467396,"delay":0,"changeRate":0.0115,"floatShares":1409000000,"shares":1427000000,"eps":0.2625,"marketStatus":"已收盘","change":0.06,"latestTime":"02-04 15:00:00","open":5.19,"high":5.27,"low":5.17,"amount":65088800,"amplitude":0.0192,"askPrice":5.27,"askSize":2320,"bidPrice":5.26,"bidSize":266,"shortable":0,"etf":0,"ttmEps":0.2625,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770255000000},"marketStatusCode":5,"adr":0,"adjPreClose":5.2,"symbolType":"stock","openAndCloseTimeList":[[1770168600000,1770175800000],[1770181200000,1770188400000]],"highLimit":5.72,"lowLimit":4.68,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1427088265,"isCdr":false,"pbRate":1.38,"roa":"--","peRate":20.038095,"roe":"3.22%","epsLYR":0.29,"committee":0.044987,"marketValue":7506000000,"turnoverRate":0.0088,"status":0,"floatMarketCap":7413000000},"requestUrl":"/m/hq/s/000597","defaultTab":"news","newsList":[{"id":"2608885730","title":"东北制药（000597）披露诉讼进展公告，2月2日股价下跌2.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608885730","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608885730?lang=zh_cn&edition=full","pubTime":"2026-02-02 17:56","pubTimestamp":1770026177,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，东北制药报收于5.15元，较前一交易日下跌2.83%，最新总市值为73.5亿元。该股当日开盘5.27元，最高5.3元，最低5.15元，成交额达9552.82万元，换手率为1.3%。近日，东北制药披露《诉讼进展公告》。涉案金额2,792.5万元已计入公司2024年度损益，案件受理费及执行费合计45.85万元，预计减少2025年度损益。截至公告日，相关款项已扣划完毕。公司及控股子公司无其他应披露未披露的重大诉讼或仲裁事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200026699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","000597"],"gpt_icon":0},{"id":"2601611403","title":"东北制药：截至2025年12月31日持有人数约4.74万","url":"https://stock-news.laohu8.com/highlight/detail?id=2601611403","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601611403?lang=zh_cn&edition=full","pubTime":"2026-01-08 20:48","pubTimestamp":1767876534,"startTime":"0","endTime":"0","summary":"证券之星消息，东北制药(000597)01月07日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至12月31日公司股东人数多少？谢谢！东北制药回复：投资者您好，根据中国结算深圳分公司提供的数据，截至2025年12月31日，持有人数约4.74万。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800036818.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000597","BK0191"],"gpt_icon":0},{"id":"2601279813","title":"东北制药（000597）披露非独立董事辞职暨选举职工代表董事公告，1月6日股价上涨0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601279813","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601279813?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:32","pubTimestamp":1767709938,"startTime":"0","endTime":"0","summary":"近日，东北制药集团股份有限公司发布关于非独立董事辞职暨选举职工代表董事的公告。公告称，公司董事会收到非独立董事王新鹏先生的书面辞职报告，因公司治理结构调整，王新鹏先生辞去第十届董事会非独立董事职务，辞职后仍担任公司其他职务。王新鹏先生未持有公司股份，其辞职不影响董事会正常运作。公司于2026年1月4日召开职工代表团（组）长联席会，选举王新鹏先生为第十届董事会职工代表董事，任期至本届董事会任期届满。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600042608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","000597","BK0239"],"gpt_icon":0},{"id":"2593472534","title":"东北制药：截至2025年12月19日持有人数约4.80万","url":"https://stock-news.laohu8.com/highlight/detail?id=2593472534","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593472534?lang=zh_cn&edition=full","pubTime":"2025-12-24 20:51","pubTimestamp":1766580717,"startTime":"0","endTime":"0","summary":"证券之星消息，东北制药(000597)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司截止到12.20日的股东人数是多少?谢谢！东北制药回复：投资者您好，2025年12月20日为非交易日。根据中国结算深圳分公司提供的数据，截至2025年12月19日，持有人数约4.80万。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400037431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000597","BK0239","BK0191"],"gpt_icon":0},{"id":"2593022499","title":"东北制药最新公告：开展股东回馈活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2593022499","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593022499?lang=zh_cn&edition=full","pubTime":"2025-12-23 18:30","pubTimestamp":1766485851,"startTime":"0","endTime":"0","summary":"东北制药(000597.SZ)公告称，为感谢股东支持，提高股东对公司内在价值的理解，同时推广自有美妆品牌，公司将开展股东回馈活动。活动时间为2025年12月25日至28日，参与范围为2025年12月8日收市时登记在册的持有公司股份500股（含）以上的股东。活动内容包含“买1得4”和专享9折优惠。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300030765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","000597"],"gpt_icon":0},{"id":"2592164215","title":"东北制药：截至2025年12月10日持有人数约4.80万","url":"https://stock-news.laohu8.com/highlight/detail?id=2592164215","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592164215?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:52","pubTimestamp":1766148750,"startTime":"0","endTime":"0","summary":"证券之星消息，东北制药(000597)12月18日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年12月10日股东人数是多少？东北制药回复：投资者您好，根据中国结算深圳分公司提供的数据，截至2025年12月10日，持有人数约4.80万。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900036489.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","000597"],"gpt_icon":0},{"id":"2591648642","title":"东北制药（000597）披露取消监事会及修订公司章程等议案获股东会通过，12月15日股价下跌1.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591648642","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591648642?lang=zh_cn&edition=full","pubTime":"2025-12-15 22:28","pubTimestamp":1765808938,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘，东北制药报收于5.27元，较前一交易日下跌1.31%，最新总市值为75.21亿元。根据近日发布的公告，东北制药于2025年12月15日召开2025年第二次临时股东会，审议通过了关于变更公司注册资本、股份总数、取消监事会并修订《公司章程》的议案，以及修订多项公司治理制度的议案，包括股东会议事规则、董事会议事规则、独立董事工作细则等。北京德恒律师事务所对本次会议出具法律意见，认为决议合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500036014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","000597","BK0239"],"gpt_icon":0},{"id":"2588062046","title":"东北制药：截至2025年11月最后一个交易日持有人数约4.82万","url":"https://stock-news.laohu8.com/highlight/detail?id=2588062046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588062046?lang=zh_cn&edition=full","pubTime":"2025-12-03 20:51","pubTimestamp":1764766276,"startTime":"0","endTime":"0","summary":"证券之星消息，东北制药(000597)12月02日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至11月30日的股东人数是多少？谢谢东北制药回复：投资者您好，根据中国结算深圳分公司提供的数据，截至2025年11月最后一个交易日，持有人数约4.82万。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300037180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","000597","BK0239"],"gpt_icon":0},{"id":"2586240124","title":"东北制药：截至2025年11月20日持有人数约4.79万","url":"https://stock-news.laohu8.com/highlight/detail?id=2586240124","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586240124?lang=zh_cn&edition=full","pubTime":"2025-11-27 20:48","pubTimestamp":1764247705,"startTime":"0","endTime":"0","summary":"证券之星消息，东北制药(000597)11月26日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司截至11月20日的股东人数是多少，谢谢东北制药回复：投资者您好，根据中国结算深圳分公司提供的数据，截至2025年11月20日，持有人数约4.79万。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700035364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","000597"],"gpt_icon":0},{"id":"2578936792","title":"东北制药(000597)9月30日股东户数4.97万户，较上期减少0.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578936792","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578936792?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:26","pubTimestamp":1761643612,"startTime":"0","endTime":"0","summary":"证券之星消息，近日东北制药披露，截至2025年9月30日公司股东户数为4.97万户，较9月19日减少204.0户，减幅为0.41%。在化学制药行业个股中，东北制药股东户数高于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.38万户。从股价来看，2025年9月19日至2025年9月30日，东北制药区间跌幅为3.09%，在此期间股东户数减少204.0户，减幅为0.41%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800031400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000597","BK0191"],"gpt_icon":0},{"id":"2578627859","title":"图解东北制药三季报：第三季度单季净利润同比下降14.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578627859","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578627859?lang=zh_cn&edition=full","pubTime":"2025-10-28 02:47","pubTimestamp":1761590839,"startTime":"0","endTime":"0","summary":"证券之星消息，东北制药2025年三季报显示，公司主营收入54.78亿元，同比下降10.69%；归母净利润1.73亿元，同比下降16.96%；扣非净利润1.32亿元，同比下降4.32%；其中2025年第三季度，公司单季度主营收入16.25亿元，同比下降17.28%；单季度归母净利润4352.45万元，同比下降14.92%；单季度扣非净利润4278.91万元，同比上升27.54%；负债率58.99%，投资收益841.43万元，财务费用902.14万元，毛利率35.03%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800002200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000597"],"gpt_icon":0},{"id":"2575413260","title":"东北制药(000597)9月30日股东户数4.97万户，较上期减少0.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575413260","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575413260?lang=zh_cn&edition=full","pubTime":"2025-10-14 17:15","pubTimestamp":1760433338,"startTime":"0","endTime":"0","summary":"证券之星消息，近日东北制药披露，截至2025年9月30日公司股东户数为4.97万户，较9月19日减少200.0户，减幅为0.4%。在化学制药行业个股中，东北制药股东户数高于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.23万户。从股价来看，2025年9月19日至2025年9月30日，东北制药区间跌幅为3.09%，在此期间股东户数减少200.0户，减幅为0.4%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400053609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","000597"],"gpt_icon":0},{"id":"2574972363","title":"股市必读：东北制药(000597)股东户数4.99万户，较上期减少2.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574972363","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574972363?lang=zh_cn&edition=full","pubTime":"2025-10-09 04:02","pubTimestamp":1759953742,"startTime":"0","endTime":"0","summary":"截至2025年9月30日收盘，东北制药报收于5.33元，上涨0.19%，换手率0.59%，成交量8.35万手，成交额4447.44万元。股本股东变化股东户数变动截至2025年9月19日，公司股东户数为4.99万户，较8月20日减少1200户，减幅2.35%；户均持股数量由上期的2.79万股上升至2.86万股，户均持股市值为15.73万元。DCTY0801注射液为靶向EGFRvIII突变抗原的CAR-T细胞产品，该突变在胶质母细胞瘤患者中约占30%，且仅表达于肿瘤细胞。目前针对该靶点的免疫治疗药物较为有限。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900001144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","000597","BK0239"],"gpt_icon":0},{"id":"2573698580","title":"东北制药：千余名员工坚守岗位 书写保产保供“节日答卷”","url":"https://stock-news.laohu8.com/highlight/detail?id=2573698580","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573698580?lang=zh_cn&edition=full","pubTime":"2025-10-05 06:07","pubTimestamp":1759615620,"startTime":"0","endTime":"0","summary":"千余名员工以“为国制药”的初心使命，坚守岗位保产保供。在东北制药，检验、能源、环保、物流等辅助保障部门同样同步“在线”。 从原料药生产到制剂保供，从一线操作到后勤保障，从厂区车间到药房门店，东北制药人用双肩扛起责任，用坚守诠释担当。这个假期，他们以生产线上的忙碌、岗位上的专注，共同书写着属于东北制药人的“国庆答卷”。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-10-05/doc-infsuqsx5676220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0191","BK0239","000597"],"gpt_icon":0},{"id":"2571310763","title":"东北制药(000597)9月19日股东户数4.99万户，较上期减少2.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571310763","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571310763?lang=zh_cn&edition=full","pubTime":"2025-09-30 17:19","pubTimestamp":1759223991,"startTime":"0","endTime":"0","summary":"证券之星消息，近日东北制药披露，截至2025年9月19日公司股东户数为4.99万户，较8月20日减少1200.0户，减幅为2.35%。在化学制药行业个股中，东北制药股东户数高于行业平均水平，截至9月19日，化学制药行业平均股东户数为3.24万户。从股价来看，2025年8月20日至2025年9月19日，东北制药区间跌幅为6.14%，在此期间股东户数减少1200.0户，减幅为2.35%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025093000028236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000597","BK0239","BK0191"],"gpt_icon":0},{"id":"2565407025","title":"东北制药最新公告：聘任李新为公司财务总监","url":"https://stock-news.laohu8.com/highlight/detail?id=2565407025","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565407025?lang=zh_cn&edition=full","pubTime":"2025-09-07 17:09","pubTimestamp":1757236181,"startTime":"0","endTime":"0","summary":"东北制药(000597.SZ)公告称，公司于2025年9月6日召开第十届董事会第六次会议，审议通过聘任李新为公司财务总监的议案，任期自本次会议审议通过之日起至本届董事会换届之日止。李新曾任多家公司财务部部长、总监等职务，目前担任方大炭素新材料科技股份有限公司监事会主席。李新未持有公司股票，与公司董事、监事、高级管理人员、持股5%以上股份的股东、实际控制人不存在其他关联关系。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700007479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","000597","BK0239"],"gpt_icon":0},{"id":"2564342371","title":"东北制药：维生素C产品可用作抗氧化剂清除活性氧自由基","url":"https://stock-news.laohu8.com/highlight/detail?id=2564342371","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564342371?lang=zh_cn&edition=full","pubTime":"2025-09-04 11:33","pubTimestamp":1756956824,"startTime":"0","endTime":"0","summary":"证券之星消息，东北制药(000597)09月03日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司是否有抗辐射类药品生产？东北制药回复：投资者您好，辐射使水分子电离产生羟自由基，引发氧化应激反应。维生素C产品具有很强的还原性，可用作抗氧化剂，清除活性氧自由基。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090400014224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","000597"],"gpt_icon":0},{"id":"2564817553","title":"东北制药(000597.SZ)：财务总监周雅娜辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2564817553","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564817553?lang=zh_cn&edition=full","pubTime":"2025-09-01 20:26","pubTimestamp":1756729608,"startTime":"0","endTime":"0","summary":"东北制药(000597.SZ)公布，公司董事会于近日收到公司财务总监周雅娜女士的书面辞职报告，周雅娜女士因个人身体原因申请辞去公司财务总监职务。\n\n\r\n 责任编辑：山上","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.jrj.com.cn/2025/09/01202652853298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0191","000597","BK0239"],"gpt_icon":0},{"id":"2562775484","title":"东北制药（000597）2025年中报简析：净利润同比下降17.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562775484","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562775484?lang=zh_cn&edition=full","pubTime":"2025-08-28 06:16","pubTimestamp":1756332971,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期东北制药发布2025年中报。根据财报显示，东北制药净利润同比下降17.62%。截至本报告期末，公司营业总收入38.53亿元，同比下降7.58%，归母净利润1.29亿元，同比下降17.62%。按单季度数据看，第二季度营业总收入19.05亿元，同比下降14.49%，第二季度归母净利润9285.7万元，同比下降6.37%。去年的净利率为5.64%，算上全部成本后，公司产品或服务的附加值一般。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800005837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000597"],"gpt_icon":0},{"id":"2562465759","title":"图解东北制药中报：第二季度单季净利润同比下降6.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562465759","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562465759?lang=zh_cn&edition=full","pubTime":"2025-08-27 02:19","pubTimestamp":1756232387,"startTime":"0","endTime":"0","summary":"证券之星消息，东北制药2025年中报显示，公司主营收入38.53亿元，同比下降7.58%；归母净利润1.29亿元，同比下降17.62%；扣非净利润8935.74万元，同比下降14.54%；其中2025年第二季度，公司单季度主营收入19.05亿元，同比下降14.49%；单季度归母净利润9285.7万元，同比下降6.37%；单季度扣非净利润6945.04万元，同比下降7.06%；负债率59.45%，投资收益287.17万元，财务费用-311.69万元，毛利率34.72%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082700002611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000597"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770216896782,"stockEarnings":[{"period":"1week","weight":-0.058},{"period":"1month","weight":-0.0038},{"period":"3month","weight":-0.0747},{"period":"6month","weight":-0.0988},{"period":"1year","weight":0.0625},{"period":"ytd","weight":-0.0038}],"compareEarnings":[{"period":"1week","weight":-0.0174},{"period":"1month","weight":0.0249},{"period":"3month","weight":0.0248},{"period":"6month","weight":0.1176},{"period":"1year","weight":0.2514},{"period":"ytd","weight":0.0249}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"东北制药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"47400人(较上一季度减少1.25%)","perCapita":"29732股","listingDate":"1996-05-23","address":"辽宁省沈阳市铁西区经济技术开发区昆明湖街","registeredCapital":"142708万元","survey":" 东北制药集团股份有限公司的主营业务是化学制药、医药商业、医药工程、生物医药等板块。公司的主要产品是维生素类、抗感染类、生殖系统和性激素类、神经系统类、抗艾滋病类、消化道类、麻精及含麻系列类、其他普药类、体外（生物）诊断试剂类。","listedPrice":6.68},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东北制药(000597)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东北制药(000597)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东北制药,000597,东北制药股票,东北制药股票老虎,东北制药股票老虎国际,东北制药行情,东北制药股票行情,东北制药股价,东北制药股市,东北制药股票价格,东北制药股票交易,东北制药股票购买,东北制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东北制药(000597)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东北制药(000597)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}